November 1, 2018

GERN Leads the Way In Biotech Today

Overall, healthcare and biotech were both up today, with biotech being the biggest gainer. IBB, the biotechnology ETF, was up nearly 3% today, whereas the overall healthcare sector ETF XLV was up about 0.70% as of the time of recording this content. This marks a sharp change of sentiment, since XLV has been more bullish overall for the last three quarters than has biotech, suggesting the biotechs are being bought up on the lows after sharply declining in October. GERN was a particularly bullish case today, trading up over 17% during the session. Here’s a recap of what happened.

about the author:

Mike Patton

Mike Patton took the leap into the markets beginning as a commodities broker in 2005, where he was responsible for identifying trading opportunities and executing trades on behalf of clients. After years as a broker he made the jump to education by joining the team at Trading Advantage, now Prosper Trading Academy.

Read Similar Articles

January 21, 2026

Could Penny Stocks Be The Big Play In 2026?

Written By: Howard Greenberg As everyday traders put their trading plans into action for 2026, penny stocks might not be on many of their radars. It’s totally understandable why penny stocks may not appeal to the more calculated seasoned traders. Their reputations for susceptibility to manipulation, extreme volatility, and low liquidity make them way too […]

Read Article
January 13, 2026

Credit Card Interest Rate Caps: What Traders Could Expect

A high-profile policy debate has re-entered the financial spotlight surrounding credit card interest rate caps. Last week, President Donald Trump called for a temporary national cap on credit card interest rates. He proposed a maximum annual rate of 10% over a one-year period, starting January 20, 2026. President Trump’s proposal would aim to combat the […]

Read Article
December 12, 2025

Premarket Pulse Pattern: My #1 Prop Trading Strategy

What is Prop Trading? Prop trading has exploded in popularity over the last five years. It’s transformed from a niche practice into a mainstream gateway for retail traders. There’s a lot of highly skilled traders out there who are sitting on the sidelines right now for two main reasons: Prop trading addresses both issues. In […]

Read Article

Read Similar Articles

https://www.prospertrading.com/charlie-moon-breaks-down-354-0dte-trade-in-nvda/Charlie Moon Breaks Down 354%* 0DTE Trade In NVDA
February 11, 2026

Charlie Moon Breaks Down 354%* 0DTE Trade In NVDA

0DTE (zero days to expiration) options can be boom or bust. For those unfamiliar, a 0DTE trade involves trading options, whose contracts expire the following day. They’re designed to enter, hold overnight, and exit the next morning. If you follow the right steps and know what to look for, these trades can net potentially explosive […]

Read Article
https://www.prospertrading.com/is-the-boom-over-for-ai-stocks/Is The Boom Over For AI Stocks?
February 6, 2026

Is The Boom Over For AI Stocks?

Many traders started wondering if the AI stocks boom has come to an end. It’s hard to blame them after seeing how some of the market’s biggest AI stocks performed this past week… ORCL: Down 16%… AMD: Down 11%… AMZN: Down 11%… NVDA: Down 10%… GOOG: Down 10%… But could Friday’s AI stock rally indicate […]

Read Article
https://www.prospertrading.com/ibm-stock-scott-trade-84-result/IBM Stock: Scott’s Breaks Down Trade Signal Showing 84%* Result
January 31, 2026

IBM Stock: Scott’s Breaks Down Trade Signal Showing 84%* Result

IBM stock was among the latest notable moves that turned heads this earnings season. The stock jumped over eight percent, after beating earnings expectations, along with the company’s encouraging growth in software and its AI book of business. Scott Bauer already had IBM stock on his radar going into their quarterly report. He released a […]

Read Article